These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6237116)

  • 21. Characteristics of flutamide action on prostatic and testicular functions in the rat.
    Marchetti B; Labrie F
    J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 10 days administration of percutaneous dihydrotestosterone on the pituitary-testicular axis in normal men.
    Kuhn JM; Rieu M; Laudat MH; Forest MG; Pugeat M; Bricaire H; Luton JP
    J Clin Endocrinol Metab; 1984 Feb; 58(2):231-5. PubMed ID: 6363434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary function test and endocrine status in patient with cirrhosis of the liver before and after hepatic transplantation.
    Seehofer D; Steinmueller T; Graef KJ; Rayes N; Wiegand W; Tullius SG; Settmacher U; Neuhaus P
    Ann Transplant; 2002; 7(2):32-7. PubMed ID: 12416470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of a GnRH agonist with an antiandrogen or bromocriptine in the treatment of prostatic cancer; slight potentiation of antigonadal effects.
    Huhtaniemi I; Parvinen M; Venho P; Rannikko S
    Int J Androl; 1991 Oct; 14(5):374-86. PubMed ID: 1839022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of immunoradiometric and bioactive follicle stimulating hormone secretion and clearance in young and elderly men during treatment with tamoxifen or flutamide.
    Urban RJ; Dahl KD; Lippert MC; Veldhuis JD
    J Androl; 1992; 13(6):579-86. PubMed ID: 1293137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
    Meriggiola MC; Bremner WJ; Paulsen CA; Valdiserri A; Incorvaia L; Motta R; Pavani A; Capelli M; Flamigni C
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3018-23. PubMed ID: 8768868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
    Wang CF; Lasley BL; Yen SS
    J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
    Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foetal exposure to low doses of cyproterone acetate in the rat leads to functional endocrine abnormalities despite normal sexual morphogenesis.
    Gómez F; Monnier B; Lemarchand-Béraud T
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):411-9. PubMed ID: 6331040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatization mediates testosterone's short-term feedback restraint of 24-hour endogenously driven and acute exogenous gonadotropin-releasing hormone-stimulated luteinizing hormone and follicle-stimulating hormone secretion in young men.
    Schnorr JA; Bray MJ; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2600-6. PubMed ID: 11397860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.
    Bhasin S; Yuan QX; Steiner BS; Swerdloff RS
    J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cyproterone acetate (CPA) on gonadal and adrenal function in men.
    de la Torre B; Norén S; Hedman M; Diczfalusy E
    Contraception; 1979 Oct; 20(4):377-96. PubMed ID: 228907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene.
    Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic-pituitary-testicular axis and seminal parameters in hyperthyroid males.
    Abalovich M; Levalle O; Hermes R; Scaglia H; Aranda C; Zylbersztein C; Oneto A; Aquilano D; Gutierrez S
    Thyroid; 1999 Sep; 9(9):857-63. PubMed ID: 10524563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that androgen negative feedback regulates hypothalamic gonadotropin-releasing hormone impulse strength and the burst-like secretion of biologically active luteinizing hormone in men.
    Veldhuis JD; Urban RJ; Dufau ML
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1227-35. PubMed ID: 1592863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency.
    Luboshitzky R; Lavi S; Thuma I; Lavie P
    J Clin Endocrinol Metab; 1996 Feb; 81(2):770-4. PubMed ID: 8636302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism.
    Szilágyi G; Szabolcs I; Vydra G; Góth M; Irsy G
    Acta Med Hung; 1984; 41(4):175-83. PubMed ID: 6440114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.